The biotech industry has broadly been on the upswing, with the SPDR S&P Biotech ETF up 43% in the past 12 months, but many rare disease names are facing a measurably higher bar from investors. There’s ...
The company's approval to upgrade to the OTCQB Venture Market underscores a growing trend among international, growth-stage companies to expand U.S. investor access and enhance market liquidity. The ...
Fraunhofer is developing the gammaSTAR software platform and SpinIt project to accelerate the transfer of innovative MRI technologies into clinical routine use. The vendor-neutral gammaSTAR platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results